Panel

Biologics-Focused FDA Panel to Review Johnson & Johnson and Legend Biotech Supplemental Applications

by

Silver Spring, Maryland – The FDA’s Oncologic Drugs Advisory Committee will convene on Friday, March 15th to review Johnson & Johnson and Legend Biotech Corporation’s supplemental biologics license application for Carvykti, a treatment for relapsed or refractory multiple myeloma patients. The primary focus of the meeting will be to evaluate the risk-benefit assessment of ciltacabtagene-autoleucel … Read more

Maine Police Defend Response to Deadly Mass Shooting as Independent Panel Investigates

by

AUGUSTA, Maine – Maine state police have faced criticism for their search efforts following a mass shooting at a bowling alley and bar last fall, where 18 people were killed. The shooter, Robert Card, died by suicide, but it took police two days to discover his body. The delay in finding Card’s body led to … Read more